Three new 3-formyl-2-arylbenzofurans from Itea yunnanensis and their anti-hepatocellular carcinoma effects

References

• Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen YH, Park JW, et al. 2018. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 379(1):54–63.
   PubMed Web of Science ®Google Scholar
• Ayers BJ, Hollinshead J, Saville AW, Nakagawa S, Adachi I, Kato A, Izumori K, Bartholomew B, Fleet GWJ, Nash RJ. 2014. Iteamine, the first alkaloid isolated from Itea virginica L. inflorescence. Phytochemistry. 100:126–131.
   PubMed Web of Science ®Google Scholar
• Balogh J, Victor D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP. 2016. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 3:41–53.
   PubMed Web of Science ®Google Scholar
• Bohm BA, Chalmers G, Bhat UG. 1988. Flavonoids and the relationship of Itea to the Saxifragaceae. Phytochemistry. 27(8):2651–2653.
   Web of Science ®Google Scholar
• Bohm BA, Yang JY, Page JE, Soltis DS. 1999. Flavonoids, DNA and relationships of Itea and Pterostemon. Biochem Syst Ecol. 27(1):79–83.
   Web of Science ®Google Scholar
• Bruix J, Qin SK, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, et al. 2017. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 389(10064):56–66.
   PubMed Web of Science ®Google Scholar
• Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH. 2004. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Mol Pharmacol. 65(1):77–84.
   PubMed Web of Science ®Google Scholar
• China National Corporation of Traditional & Herbal Medicine. 1994. Notes on resource of traditional Chinese medicine. Beijing: Science Press. p. 481–482.
   Google Scholar
• Chu CY. 2009. Chemical constituents and antitubercular activity from the roots of Itea parviflora. Kaohsiung: Kaohsiung Medical University.
   Google Scholar
• Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H. 2009. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr. 42(2):339–341.
   Web of Science ®Google Scholar
• Dominguez XA, Sánchez VH, Espinoza BGC, Verde SJ, Achenbach H, Utz W. 1990. Lignans and nor-neolignans from Krameria interior. Phytochemistry. 29(8):2651–2653.
   Web of Science ®Google Scholar
• Editorial committee of Flora of China, the Chinese Academy of Sciences. 1995. Flora Reipublicae Popularis Sinicae. Beijing: Science Press. p. 261.
   Google Scholar
• El-Khoueiry AB, Melero I, Yau TC, Crocenzi TS, Kudo M, Hsu C, Choo SP, Trojan J, Welling T, Meyer T, et al. 2018. Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (NIVO) in patients with advanced hepatocellular carcinoma (aHCC): subanalyses of CheckMate-040. J Clin Oncol. 36(4):475.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. 2018. Hepatocellular carcinoma. Lancet. 391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Halabalaki M, Alexi X, Aligiannis N, Alexis MN, Skaltsounis AL. 2008. Ebenfurans IV-VIII from Onobrychis ebenoides: evidence that C-prenylation is the key determinant of the cytotoxicity of 3-formyl-2-arylbenzofurans. J Nat Prod. 71(11):1934–1937.
   PubMed Web of Science ®Google Scholar
• Himmelreich U, Ripperger H, Adam G, Anh NH, Van Sung T. 1995. Eupomatenoids from Cavyodaphnosis tonkinensis and their complete NMR assignment. Magn Reson Chem. 33(4):280–282.
   Web of Science ®Google Scholar
• Horibe T, Ohmura S, Ishihara K. 2019. Structure and reactivity of aromatic radical cations generated by FeCl3. J Am Chem Soc. 141(5):1877–1881.
   PubMed Web of Science ®Google Scholar
• Katsanou ES, Halabalaki M, Aligiannis N, Mitakou S, Skaltsounis AL, Alexi X, Pratsinis H, Alexis MN. 2007. Cytotoxic effects of 2-arylbenzofuran phytoestrogens on human cancer cells: modulation by adrenal and gonadal steroids. J Steroid Biochem Mol Biol. 104(3-5):228–236.
   PubMed Web of Science ®Google Scholar
• Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, et al. 2018. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 391(10126):1163–1173.
   PubMed Web of Science ®Google Scholar
• Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. 2016. The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC). Oncol Lett. 12(5):3045–3050.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen J, Cao M, Wang J, Wang S. 2019. NO donor inhibits proliferation and induces apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells. Cancer Chemother Pharmacol. 84(6):1303–1314.
   PubMed Web of Science ®Google Scholar
• Liu K, Tian T, Zheng Y, Zhou L, Dai C, Wang M, Lin S, Deng Y, Hao Q, Zhai Z, et al. 2019. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway. J Cell Mol Med. 23(4):3040–3044.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Montal R, Sia D, Finn RS. 2018. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 15(10):599–616.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, et al. 2008. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359(4):378–390.
   PubMed Web of Science ®Google Scholar
• Luo G, Zhou M, Liu Y, Ye Q, Gu J, Huang T, Zhang G, Luo Y. 2014. 3-Formyl-2-arylbenzofurans from the aerial parts of Itea ilicifolia. Phytochem Lett. 10:19–22.
   Web of Science ®Google Scholar
• van Meer S, de Man RA, Coenraad MJ, Sprengers D, van Nieuwkerk KMJ, Klümpen HJ, Jansen PLM, IJzermans JNM, van Oijen MGH, Siersema PD, et al. 2015. Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol. 63(5):1156–1163.
   PubMed Web of Science ®Google Scholar
• Morelli L, Bernardi A, Sattin S. 2014. Synthesis of potential allosteric modulators of Hsp90 by chemical glycosylation of eupomatenoid-6. Carbohyd Res. 390:33–41.
   PubMed Web of Science ®Google Scholar
• Sheldrick GM. 2015a. SHELXT - integrated space-group and crystal-structure determination. Acta Crystallogr A Found Adv. 71(Pt 1):3–8.
   PubMed Web of Science ®Google Scholar
• Sheldrick GM. 2015b. Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem. 71(Pt 1):3–8.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Mino T, Masuda C, Yoshida Y, Sakamoto M. 2019. Synthesis of 7-allylated benzofuran derivative from o-allyloxyethynylbenzene via Claisen rearrangement and TBAF catalyzed annulation. Eur J Org Chem. 2019(7):1635–1645.
   Web of Science ®Google Scholar
• Whittaker S, Marais R, Zhu AX. 2010. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 29(36):4989–5505.
   PubMed Web of Science ®Google Scholar